Samsung Biologics
Samsung Biologics
Revolutionizing Oral Biologic Delivery: Tiny VHH Antibodies
🔍 Discover how VHH antibodies could revolutionize oral delivery of biologics, overcoming challenges for better absorption and stability.
Revolutionary Model Predicts Biologic Processing Variations
🔍 Scientists have developed a mathematical model to predict RTD in continuous manufacturing of biologics. 🔬🔬🧪💯🔬
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
Boosting Lyophilization Productivity by 300: A Game-Changing Digital Twin Approach
📰 Researchers at Clausthal University of Technology in Germany have found that using a digital twin approach during the freeze-drying process for biologics can increase productivity by up to 300 🚀💰. This approach also reduces costs by 74 💵 and lowers the global warming potential by 64 🌍. Lyophilization DigitalTwin
Samsung Biologics and LegoChem unite to revolutionize cancer treatment
🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.
